Daily Market Report: February 24, 2026

Market Overview

U.S. stocks experienced a significant downturn on Monday, February 23, 2026, as investor sentiment was soured by a combination of concerns over artificial intelligence (AI) disruption and renewed uncertainty surrounding U.S. trade policy. The sell-off was broad-based, with the S&P 500 falling 1.0% to 6,837.75, the Dow Jones Industrial Average dropping 1.7% to 48,804.06, and the Nasdaq Composite sliding 1.1% to 22,627.27. The market anxiety was palpable, with the CBOE Volatility Index (VIX) closing above 21, reflecting heightened investor nervousness. European markets mirrored the U.S. decline, with the Stoxx Europe 600 and Germany’s DAX both closing in negative territory. In contrast, Asian markets presented a mixed picture, with Hong Kong’s Hang Seng Index bucking the trend to post a 2.5% gain on optimism regarding a potentially lower tariff burden for China.

Top Market Movers

Several individual stocks made significant moves, driven by company-specific news and broader market themes:

• IBM (NYSE: IBM): The technology giant’s shares plummeted by as much as 13.2%, marking their steepest single-day decline since 2000. The dramatic sell-off was triggered by a blog post from AI startup Anthropic, which claimed its new AI model, Claude Code, could automate the modernization of COBOL, a legacy programming language that is a cornerstone of IBM’s mainframe business. Investment implications: This development highlights the disruptive potential of AI, even for established tech behemoths. Investors in legacy tech companies should closely monitor the pace of AI innovation and its potential to erode existing business models.
• Nvidia (NASDAQ: NVDA): In a bright spot for the tech sector, Nvidia’s stock rose 0.9% ahead of its highly anticipated earnings report. The chipmaker has been at the forefront of the AI boom, and its results are seen as a key barometer for the health of the broader technology sector. Investment implications: Nvidia’s performance is a crucial indicator of the ongoing AI investment cycle. A strong report could reignite bullish sentiment in the tech sector, while any signs of a slowdown could have a ripple effect across the market.
• Eli Lilly (NYSE: LLY): The pharmaceutical company’s shares climbed 4.8% after its rival, Novo Nordisk, announced disappointing results from a head-to-head clinical trial. Novo Nordisk’s experimental obesity drug, CagriSema, failed to show non-inferiority to Eli Lilly’s popular drug, Zepbound. Investment implications: This news solidifies Eli Lilly’s dominant position in the lucrative weight-loss drug market. The competitive landscape in the pharmaceutical sector is dynamic, and clinical trial results can have a significant and immediate impact on stock prices.
• PayPal (NASDAQ: PYPL): The digital payments company’s stock gained 5.8% following reports of takeover interest from at least one suitor. The news comes after a period of significant underperformance for PayPal’s stock, which has lost a substantial portion of its market value over the past year. Investment implications: Takeover speculation can provide a short-term boost to a company’s stock price. However, long-term investors should focus on the underlying fundamentals of the business and the potential for a strategic acquisition to create sustainable value.

Economic Data & Fed Watch

The macroeconomic landscape continues to be a key focus for investors, with all eyes on the Federal Reserve and the trajectory of interest rates. Federal Reserve Governor Christopher Waller provided a cautious outlook, stating that a March rate cut is a “coin flip” and that he needs to see more data before making a definitive judgment on the health of the labor market. While the January jobs report was stronger than expected, Governor Waller expressed some skepticism, suggesting it may contain “more noise than signal.” The 10-year Treasury yield, a key benchmark for borrowing costs, hovered around the 4.03-4.04% level. Recent economic data has been mixed, with U.S. manufactured goods orders declining in December, while the Dallas Fed’s Texas manufacturing index indicated stable conditions in February. Upcoming data releases, including the weekly ADP employment change and consumer confidence figures, will be closely watched for further clues on the state of the economy. Investment implications: The Federal Reserve’s policy decisions will be a major driver of market performance in the coming months. A more hawkish stance could put pressure on stocks, while a dovish pivot could provide a tailwind. Investors should pay close attention to economic data and Fed commentary to gauge the likely path of monetary policy.

International Markets

Global markets were also impacted by the prevailing sense of uncertainty. In Europe, the Stoxx Europe 600 fell 0.5%, and Germany’s DAX slipped 1.1%. The declines were driven by the same concerns over AI disruption and trade policy that weighed on U.S. markets. Asian markets were a mixed bag, with Japan and mainland China closed for holidays. However, Hong Kong’s Hang Seng Index was a notable outperformer, surging 2.5% on hopes that a recent U.S. court ruling could lead to a lower tariff burden for Chinese companies. The U.S. dollar was broadly firmer, while the Japanese yen weakened.

Looking Ahead

Investors will be looking ahead to a busy week of earnings reports and economic data releases. In addition to Nvidia, other major companies scheduled to report earnings include HSBC, Lowe’s, Salesforce, and Dell. On the economic front, the weekly ADP employment change, Philadelphia Non-Manufacturing Activity, and consumer confidence data will provide further insights into the health of the U.S. economy. The market will also be closely monitoring any developments related to U.S. tariff policy and the ongoing Iran nuclear talks, both of which have the potential to be significant market catalysts.

Disclaimer: This analysis is for informational and educational purposes only and should not be considered financial advice. Market conditions can change rapidly, and past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.